Neurogel en Marche Assocation is a registered non-profit organization, recognized of public interest, and holder of the patent for NEUROGEL™.

Unique in the world of medical research, the Association brings together paralyzed people and researchers who have mobilized to promote a first human trial with a groundbreaking strategy to cure spinal cord injury.

Operations of the spinal cord at the Kunming Center in China

Treatment of chronic lesions of the spinal cord using activated fat

In 2018, Association NEUROGEL En Marche in partnership with THE INTERNATIONAL SPINAL CORD INJURY TREATMENT CENTER, at the Tongren Hospital in Kunming, China has plans underway to conduct a series of operations using activated fat, a three-dimensional autologous matrix derived from adipose tissue, combined with erythropoietin (EPO). Treatment of chronic lesions of the spinal cord using activated fat

 

All documentation and forms